Qube Research & Technologies »

Catalyst Pharmaceutical Partners shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 90k 15.94
2023-09-30 $755k 65k 11.69
2022-12-31 $2.3M 122k 18.60
2022-06-30 $860k 123k 7.01
2022-03-31 $1.3M 154k 8.29
2021-12-31 $1.2M 178k 6.77
2021-09-30 $448k 85k 5.30
2021-06-30 $255k 44k 5.76
2020-03-31 $131k 34k 3.85

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners